These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20232740)

  • 1. [The influence of estazolam on human neurobehavioral function].
    Bu J; Zhuo XY
    Fa Yi Xue Za Zhi; 2010 Feb; 26(1):30-2. PubMed ID: 20232740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relation of blood alcohol concentration and neurobehavioral functions after drinking].
    Zhuo XY; Bu J; Xiang P; Shen BH
    Fa Yi Xue Za Zhi; 2008 Aug; 24(4):265-7. PubMed ID: 18817036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobehavioral performance of adult and adolescent agricultural workers.
    Rohlman DS; Lasarev M; Anger WK; Scherer J; Stupfel J; McCauley L
    Neurotoxicology; 2007 Mar; 28(2):374-80. PubMed ID: 17141876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible neurobehavioral performance with reductions in blood lead levels--a prospective study on lead workers.
    Chuang HY; Chao KY; Tsai SY
    Neurotoxicol Teratol; 2005; 27(3):497-504. PubMed ID: 15939209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of 14C-estazolam in dogs and humans.
    Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
    Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
    Leufkens TR; Lund JS; Vermeeren A
    J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers.
    Iwamoto K; Kawamura Y; Takahashi M; Uchiyama Y; Ebe K; Yoshida K; Iidaka T; Noda Y; Ozaki N
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):610-6. PubMed ID: 18950383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Driving fitness/driving capacity of patients treated with methadone].
    Hauri-Bionda R; Bär W; Friedrich-Koch A
    Schweiz Med Wochenschr; 1998 Oct; 128(41):1538-47. PubMed ID: 9816613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Test performance with minimal alcoholic intoxication].
    Bartl G; Lager F; Domesle L
    Blutalkohol; 1996 Jan; 33(1):1-16. PubMed ID: 8777031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pallidal index on MRI as a target organ dose of manganese: structural equation model analysis.
    Kim E; Kim Y; Cheong HK; Cho S; Shin YC; Sakong J; Kim KS; Yang JS; Jin YW; Kang SK
    Neurotoxicology; 2005 Jun; 26(3):351-9. PubMed ID: 15935207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model studies for evaluating the acute neurobehavioral effects of complex hydrocarbon solvents I. Validation of methods with ethanol.
    McKee RH; Lammers JH; Hoogendijk EM; Emmen HH; Muijser H; Barsotti DA; Owen DE; Kulig BM
    Neurotoxicology; 2006 Dec; 27(6):1064-79. PubMed ID: 16831461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between neurobehavioral performance and lung function.
    Min JY; Min KB; Paek D; Sakong J; Cho SI
    Neurotoxicology; 2007 Mar; 28(2):441-4. PubMed ID: 16716400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the NES and CNS/B neuropsychological screening batteries.
    Bowler RM; Thaler CD; Law D; Becker CE
    Neurotoxicology; 1990; 11(3):451-64. PubMed ID: 2284051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Opioids and driving ability -- a problem unsolved?].
    Sabatowski R; Berghaus G; Strumpf M; Radbruch L
    Dtsch Med Wochenschr; 2003 Feb; 128(7):337-41. PubMed ID: 12584661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of psychoactive drugs on car driving ability].
    Brunnauer A; Laux G
    Dtsch Med Wochenschr; 2008 Jun; 133 Suppl 2():S38-40. PubMed ID: 18548369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
    Ramaekers JG; Moeller MR; van Ruitenbeek P; Theunissen EL; Schneider E; Kauert G
    Drug Alcohol Depend; 2006 Nov; 85(2):114-22. PubMed ID: 16723194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobehavioral function in children with low blood lead concentrations.
    Min JY; Min KB; Cho SI; Kim R; Sakong J; Paek D
    Neurotoxicology; 2007 Mar; 28(2):421-5. PubMed ID: 16644013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fitness to drive in spite (because) of THC].
    Strohbeck-Kühner P; Skopp G; Mattern R
    Arch Kriminol; 2007; 220(1-2):11-9. PubMed ID: 17879702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):317-30. PubMed ID: 6431211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobehavioral assessment of mice after developmental AZT exposure.
    Levin ED; Brunssen S; Wolfe GW; Harry GJ
    Neurotoxicol Teratol; 2004; 26(1):65-71. PubMed ID: 15001215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.